ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 23 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,730,241 | +6.1% | 46,411,000 | 0.0% | 0.13% | -17.4% |
Q2 2023 | $23,308,486 | +24.3% | 46,411,000 | 0.0% | 0.16% | -11.0% |
Q1 2023 | $18,751,436 | -25.9% | 46,411,000 | 0.0% | 0.18% | -59.2% |
Q4 2022 | $25,320,496 | -3.1% | 46,411,000 | 0.0% | 0.44% | +52.1% |
Q3 2022 | $26,134,000 | +3.5% | 46,411,000 | 0.0% | 0.29% | -1.7% |
Q2 2022 | $25,262,000 | +4.3% | 46,411,000 | 0.0% | 0.30% | +2.4% |
Q1 2022 | $24,217,000 | -2.2% | 46,411,000 | 0.0% | 0.29% | +7.8% |
Q4 2021 | $24,770,000 | – | 46,411,000 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 18,764 | $9,907,000 | 0.77% |
Pentwater Capital Management LP | 46,411,000 | $24,770,000 | 0.27% |
WHITEBOX ADVISORS LLC | 22,500,000 | $11,756,000 | 0.24% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $10,993,000 | 0.23% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,590,000 | $9,286,000 | 0.20% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $12,540,000 | 0.18% |
BlueCrest Capital Management Ltd | 7,000,000 | $3,705,000 | 0.12% |
DCF Advisers, LLC | 400,000 | $211,000 | 0.09% |
Walleye Capital LLC | 5,000 | $2,638,000 | 0.08% |
INGALLS & SNYDER LLC | 883,000 | $461,000 | 0.02% |